LSZ: Difference between revisions

From TripSit wiki
Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
= Dosage =
= Dosage =


Light: 100-150 μg
{| class="wikitable"
 
|+ Oral
Common: 150-300 μg
|-
 
| Light || 100-150μg
Strong: 300+ μg
|-
| Common || 150-300μg
|-
| Strong || 300μg+
|}


= Duration =
= Duration =


Onset: 90-120 minutes
{| class="wikitable"
 
|+ Oral
Total: 7-10 hours
|-
| Onset || 90-120 minutes
|-
| Total || 7-10 hours
|}


= Effects =
= Effects =

Revision as of 13:53, 16 July 2014

LSZ, also known as Lysergic acid 2,4-dimethylazetidide, is a hallucinogenic drug and an analogue of LSD developed by the team led by David E. Nichols at Purdue University. While LSZ has subtly different effects than LSD, it appears to be slightly longer lasting and slightly more potent.

Dosage

Oral
Light 100-150μg
Common 150-300μg
Strong 300μg+

Duration

Oral
Onset 90-120 minutes
Total 7-10 hours

Effects

While LSD has subtly different effects than LSD, it appears to be slightly longer lasting while also having a longer comeup.

Harm Reduction

While widespread use of LSZ is relatively new and therefore its full impact is unknown, it is likely that it has a similar safety profile to LSD. Refer to LSD and Psychedelic Harm Reduction for more information.

Legal status

America

Controlled in the United States via the Federal Analog Act but only if it is intended for human consumption.